ArticleOPEN ACCESS

Erratum to: Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I (Journal of Antimicrobial Chemotherapy (2019) 74 (3555-3564) DOI: 10.1093/jac/dkz347)

Journal of Antimicrobial Chemotherapy
DOI: 10.1093/jac/dkz412
2Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An error was present in the original published version of this article. In Table 4, in the penultimate row, the entry 'Week 12' in the RT column should have read 'none'. This has now been corrected. (Table Presented).

Cite

CITATION STYLE

APA

Andreatta, K., Willkom, M., Martin, R., Chang, S., Wei, L., Liu, H., … White, K. L. (2019, December 1). Erratum to: Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I (Journal of Antimicrobial Chemotherapy (2019) 74 (3555-3564) DOI: 10.1093/jac/dkz347). Journal of Antimicrobial Chemotherapy. Oxford University Press. https://doi.org/10.1093/jac/dkz412

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free